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Abstract 
 
Background: Reports of anxiety disorder characteristics among youth in clinical settings typically include descriptions of 
patients who have been specifically referred for anxiety treatment. At odds with a large body of evidence which demonstrates 
these disorders to be most common among young people, prevalence studies in samples referred to general psychiatry for 
multiple causes are scarce and report highly discrepant estimates. 
Methods: For this study and regardless of their presenting symptoms, 125 adolescents (57.6% girls) between the ages of 12 
and 18 years who were consecutively referred to two child and adolescent general psychiatry clinics in Sweden were assessed 
for anxiety disorders and comorbidity using the Schedule for Affective Disorders and Schizophrenia for School-Age Children. 
Self-ratings of anxiety symptoms and difficulties with family, school, friends, sleep, and body aches were also obtained. 
Results: At least one anxiety disorder was found in 46% of participants. Among anxious adolescents, homotypic comorbidity 
(concurrent anxiety) was observed in 43%, and heterotypic comorbidity (concurrent non-anxiety psychiatric disorders) was 
observed in 91%. No comorbidity was observed in 5%. Trauma, ache, and difficulties making friends were more common 
among anxious adolescents as compared with psychiatrically referred adolescents without anxiety. 
Conclusions: The finding that only 21% of adolescents diagnosed with anxiety disorders were referred for anxiety further 
supports the routine use of standardized and structured instruments—irrespective of referral cause—to improve both 
precision and detection rates in the clinical setting. Comprehensive assessments are of utmost importance to fully address the 
complexity of the symptoms in this patient group. 
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Introduction 
Anxiety affects 117 million youths worldwide; it is 
the sixth leading cause of disability, with the highest 
burden (i.e., time lived with the condition) among 
people who are 15 to 34 years old (1, 2). Early-onset 
anxiety is associated with adverse short- and long-
term social, academic, financial, and health 
outcomes, and it also predicts substance use 
disorders and adult anxiety (3-5). Early identification 
and treatment are critical to reduce the burden and to 
prevent negative life outcomes. However, anxiety is 
still largely unrecognized in primary and mental 
health care, and only a minority of affected children 
receives treatment (6-8). Clinicians and decision 
makers need to be aware of the presence and 
deleterious impact of childhood anxiety. However, 
there is a paucity of data regarding the prevalence and 
clinical correlates of multiple anxiety disorders in 
non-specialized psychiatric outpatient settings, where 
anxiety may not be a recognized or primary cause for 
the seeking of help (8, 9). Only three prevalence 
studies of multiple anxiety disorders in non-anxiety–
specialized psychiatric settings have been reported, 
with highly discrepant prevalence rates that make 
adequate service planning and resource allocation for 
this setting and patient group difficult tasks (10-14). 
Hammerness and colleagues (13) used the 
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for School-Age Children (K-SADS) diagnostic 
interview (15) to examine the characteristics of seven 
non–obsessive-compulsive disorder (OCD) anxiety 
disorders in 1375 psychiatrically referred children 
and adolescents in North America. According to 
diagnostic criteria presented in the Diagnostic and 
Statistical Manual of Mental Disorders, Third Edition, 
Revised (DSM-III-R) (16), the overall prevalence of 
anxiety was 57.7%, with a 53.8% homotypic 
comorbidity (concurrent anxiety disorder) rate and 
higher rates of depression, bipolar disorder, and 
pervasive developmental disorder seen among 
anxious youths as compared with youths without 
anxiety. By contrast, a much lower prevalence rate of 
5.7% was found for five non-OCD anxiety disorders 
in a Danish study of 13,241 psychiatrically referred 
youths that included data gathered from a national 
database of diagnoses from the International Statistical 
Classification of Diseases and Related Health Problems, 10th 
Revision [ICD-10] (17). Diagnoses in the database 
were determined during clinical conferences using all 
available information collected via several 
unspecified clinical tools rather than just a single 
instrument or interview (12). Moreover, homotypic 
comorbidity was found in only 2.8% of anxious 
youths, whereas heterotypic comorbidity (concurrent 
non-anxiety psychiatric disorder) was observed in 
42.9%. With the use of both data collection methods, 
six non-OCD anxiety disorders were investigated in 
407 children between the ages of 7 and 13 years who 
were referred to child and adolescent psychiatric care 
in Norway (14). A prevalence of 32.7% of DSM-IV 
anxiety disorders was found when the K-SADS 
interview was used as compared with a rate of only 
5% when data was collected from a patient register. 
On the basis of the K-SADS, homotypic 
comorbidity was observed in 24.8% of anxiety-
disordered children, and heterotypic comorbidity 
was found in 70.7%. 
The authors of the Danish and Norwegian studies 
suggested the limited use of standardized 
instruments in routine clinical practice as the main 
explanation for the low prevalence estimates derived 
from patient registers. 
In two recently conducted meta-analyses of 
community prevalence studies—one of which 
investigated mental disorders in children and 
adolescents and the other that investigated anxiety 
across all age groups—sources of prevalence 
variance were analyzed (2, 18). Sample 
representativeness, sample frame (e.g., schools, 
households), and diagnostic interviews (as contrasted 
with K-SADS) were the only significant moderators 
of prevalence and explained 88.9% of the variability 
in studies of mental disorders in youths. In 
prevalence studies of anxiety that included age 
categories across the life span, significant moderators 
of prevalence estimates (with variance explained in 
parentheses) included the following: age (1%); 
conflict (e.g., war; 2%); economic status (e.g., low- or 
middle-income country; 2%); urbanicity (2%); 
diagnostic instrument used (2%); number of anxiety 
disorders examined (4%); culture (5%); prevalence 
period (9%); and gender (25%). More research is 
needed to determine whether the moderators that 
influence anxiety prevalence variability in clinical 
studies are the same as those that influence 
community studies. 
The major objective of the present study was to 
investigate anxiety prevalence and comorbidity 
patterns among adolescents using the K-SADS 
diagnostic interview in a Scandinavian non-anxiety–
specialized psychiatric setting. Thus, anxiety among 
psychiatrically referred adolescents was characterized 
in three ways: 1) by the prevalence of seven anxiety 
disorders: social anxiety disorder, generalized anxiety 
disorder, specific phobia, panic disorder, 
agoraphobia, separation anxiety disorder, and 
unspecified anxiety disorder; 2) by clinical 
presentation; and 3) by patterns of comorbidity, 
including homotypic and heterotypic comorbidity. 
 
Methods 
Setting and Enrollment of Participants 
Patients who presented at two child and adolescent 
general psychiatric outpatient clinics in the county of 
Västmanland, Sweden, between August 2011 and 
June 2013 were eligible for enrollment. These clinics 
provide services to children and adolescents 18 years 
old and younger who live within the catchment area 
(N = 37,494). There are no specialized anxiety clinics 
in the area. Referrals to the clinics are made by 
parents, primary care physicians, social services, 
school health services, and hospital departments. 
Data from the clinics’ patient administrative systems 
showed that, in 2010 (when procedures for 
diagnostic assessment did not include the systematic 
use of structured interviews), 9.7% of all admitted 
patients between the ages of 13 and 17 years (N = 
1092) had received a diagnosis of anxiety. Patients 
were eligible if they met the age criteria (12 to 18 
years old), regardless of their presenting symptoms. 
The exclusion criteria were inadequate Swedish-
speaking skills and prior diagnosis of intellectual 
developmental disorder. During the predefined 
recruitment period, which totaled 63 weeks, 202 
patients were found to be eligible for inclusion, 
whereas 77 were excluded: 28 declined to participate, 
45 were missed as eligible and therefore not 
scheduled for the diagnostic interview, and 4 did not 
show up for the diagnostic interview. There were no 
significant differences in sex or age between the 
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excluded and included patients. Clinical staff 
confirmed eligibility, checked for exclusion criteria, 
and obtained informed written consent to participate 
from both the adolescents and their parents. The 
project was approved by the Regional Ethical Review 
Board in Uppsala. 
 
Measures 
Schedule for Affective Disorders and Schizophrenia for School-
Age Children – Present and Lifetime Version, 2009  
The K-SADS (15) is a semi-structured diagnostic 
interview designed to guide clinicians in the 
collection of evidence for 33 DSM-IV (19) 
psychiatric disorders in children and adolescents 
between the ages of 6 and 17 years. It consists of a 
screening interview; symptom severity above the 
threshold determines which additional diagnostic 
supplements should be completed. The K-SADS is 
widely used as a diagnostic tool and reference 
standard in child and adolescent mental health 
research (13, 20, 21). 
 
Spence Children’s Anxiety Scale 
Anxiety symptoms were measured using the Spence 
Children’s Anxiety Scale (SCAS) (22), a 44-item (38 
score-generating items and 6 positive filler items to 
reduce negative bias) Likert-type (0 = “never;” 3 = 
“always”) questionnaire designed to assess anxiety 
symptoms in children and adolescents. The SCAS 
provides a total score as well as scores on six 
subscales: panic attacks and agoraphobia, separation 
anxiety, physical injury fears, social phobia, OCD, 
and generalized anxiety. In the original study by 
Spence, the internal reliability coefficient for the total 
scale was 0.92, and it ranged from 0.60 to 0.82 for the 
subscales (22). In an evaluation of the psychometric 
properties of the Swedish translation of the SCAS, 
which included a subgroup of the current study 
sample, Swedish clinical cutoff scores were obtained. 
Results showed an internal reliability coefficient of 
0.94 for the total score and demonstrated the scale’s 
ability to distinguish between adolescents with and 
without an anxiety disorder in a Swedish non-
anxiety–specific clinical setting (23). 
 
Functional impairment/negative life events  
Self-reports of functional impairment and negative 
life events were collected from adolescents during 
their initial visits through a routine intake question-
naire. Items were related to problems within the 
family (any occurrence of child physical abuse in the 
family, violence between parents, or alcohol or drug 
problems in the family); difficulties in school 
(current need for extra help or current failed 
courses); interpersonal difficulties (school-related 
bullying or difficulty making new friends ); somatic 
concerns (frequent headache or stomachache or 
pain in the neck, shoulders, back, or legs during the 
last three months); and sleep concerns (during the 
last three months). On the basis of the intake 
questionnaire, nine dichotomous variables were 
computed and organized into the five functional 
domains of family, school, interpersonal, somatic, 
and sleep. 
 
Procedure 
Clinical staff registered each patient’s demographic 
data, referral cause, and source and administered the 
SCAS as well as an intake questionnaire as part of a 
regular intake routine during each participant’s first 
or second visit. A time was then scheduled for each 
patient to complete the K-SADS interview (median 
time between intake visit and interview, seven days; 
interquartile range, 15 days).  
 
Diagnostic Procedure 
Five experienced clinicians (two psychiatrists, two 
psychologists, and one counselor) received extensive 
interview training by a K-SADS teacher before data 
collection. A free-marginal multirater kappa (24, 25) 
was chosen to calculate inter-rater reliability. This 
kappa statistic differs from Cohen’s kappa in that it 
allows for multiple raters and is not dependent on 
marginal distributions. Calibration meetings were 
held monthly throughout the study, and these 
involved video recordings of randomly selected 
interviews. The average inter-rater reliability and 
percent overall agreement (Po) during data collection 
was as follows: all diagnoses, 0.94 (Po = 0.97); any 
anxiety, 0.92 (Po = 0.96); separation anxiety, 0.83 (Po 
= 0.92); social phobia, 0.92 (Po = 0.96); specific 
phobia, 0.94 (Po = 0.97); OCD, 1.00 (Po = 1.00); 
generalized anxiety disorder, 1.00 (Po = 1.00); and 
panic/agoraphobia, 0.94 (Po = 0.97). 
Adolescents and their parents were interviewed 
together. Interviewers determined the current 
presence of diagnoses on the basis of full DSM-IV 
criteria and information collected via the K-SADS 
only. Diagnoses were not classified as primary or 
secondary. Anxiety disorders included in the analyses 
of anxiety prevalence and homotypic comorbidity 
were social phobia (social anxiety), generalized 
anxiety disorder, specific phobia, separation anxiety 
disorder, panic disorder, agoraphobia, and anxiety 
not otherwise specified (unspecified anxiety 
disorder). To harmonize with the chapter on anxiety 
disorders in the DSM-5 (26), the diagnoses of OCD 
and post-traumatic stress disorder were excluded 
from the analysis of anxiety prevalence and 
homotypic comorbidity and included in the category 
of heterotypic comorbidity. If criteria for the DSM-
IV diagnosis of panic disorder with agoraphobia 
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(code 300.21) were fulfilled, both anxiety categories 
of Panic disorder and Agoraphobia were coded as 
“1” (i.e., “present”) in the analysis of prevalence and 
homotypic comorbidity. All non-anxiety disorders 
were clustered into categories in accordance with the 
organizational structure of the DSM-5. An overview 
of the categories and organization of the K-SADS–
derived DSM-IV diagnoses is presented in supple-
mentary Table S1.  
 
Data Analysis 
Statistical analyses were conducted with the use of 
SPSS 22 software running on the Windows 7 
operating system. Between-group differences were 
analyzed with independent t-tests and chi-squared 
tests. Binary logistic regression analyses were 
conducted to examine the variables associated with 
anxiety and comorbidity. In multivariate models, 
separate for each covariate, we adjusted for sex and 
age. 
 
 
 
TABLE 1. Anxiety prevalence and comorbidity among 125 psychiatrically referred adolescents 
 
 
Variables 
All Participants 
(N = 125) 
Anxious 
(n = 58) 
Non-anxious 
(n = 67) 
 
2 (df) 
 
p value 
  
Prevalence, % (95% CI) 
Anxiety disorders      
Any anxiety 46.4 (37.9-55.1)     
Social anxiety 27.2 (20.2-35.6)     
Generalized anxiety 17.6 (11.9-25.2)     
Specific phobia 16.8 (11.3-24.3)     
Panic disorder 9.6 (5.6-16.0)     
Agoraphobia 9.6 (5.6-16.0)     
Separation anxiety disorder 4.0 (1.7-9.0)     
Unspecified anxiety disorder 1.6 (0.4-5.6)     
Comorbidity      
Homotypic  43.1 (31.2-55.9)    
Without heterotypic  3.4 (1.0-11.7)    
No. of anxiety disorders:      
2  12.1 (6.0-22.9)    
3  20.7 (12.2-32.8)    
4  8.6 (3.7-18.6)    
5  1.7 (0.3-9.1)    
Heterotypic  91.4 (81.4-96.3) 83.6 /72.9-90.6)* 1.7 (1) .193 
Without homotypic  51.7 (39.2-64.1)    
Depressive 44.8 (36.4-53.5) 53.4 (40.8-65.7) 37.3 (26.7-49.3) 3.3 (1) .070 
Neurodevelopmental 56.0 (47.2-64.4) 51.7 (39.2-64.1) 59.7 (47.7-70.6) 0.8 (1) .370 
Trauma 9.6 (5.6-16.0) 15.5 (8.4-26.9) 4.5 (1.5-12.4) 4.4 (1) .037 
Conduct 14.4 (9.3-21.6) 13.8 (7.2-24.9) 14.9 (8.3-25.3) 0.0 (1) .857 
Eating 6.4 (3.3-12.1) 8.6 (3.7-18.6) 4.5 81.5-12.4) 0.9 (1) .470† 
Obsessive 7.2 (3.8-13.1) 6.9 (2.7-16.4) 7.5 3.2-16.3) 0.0 (1) 1.000† 
Psychotic 3.2 (1.3-7.9) 3.4 (1.0-11.7) 3.0 (0.8-10.2) 0.0 (1) 1.000† 
Bipolar 1.6 (0.4-5.6) 1.7 (0.3-9.1) 1.5 (0.3-8.0) 0.0 (1) 1.000† 
Substance 1.6 (0.4-5.6) 0 (0.0-6.2) 3.0 (0.8-10.2) 1.8 (1) .499† 
*Presence of one or more non-anxiety psychiatric disorder 
†Fisher’s exact test, two-tailed 
 
 
 
 
Results 
Description of Sample 
The study group consisted of 125 consecutively 
referred adolescents (72 girls; 57.6%) between the 
ages of 12 and 18 years (mean, 15.7; standard 
deviation, 1.5). The majority of the patients’ parents 
were separated (60.8%). There were multiple causes 
for referral, as described by the referral source; the 
most common were symptoms of attention-
deficit/hyperactivity disorder (31.2%) and 
depression (29.6%). Problematic symptoms of 
anxiety were reported in 18.4% of patients at the time 
of referral. Among those referred for more than one 
cause (38 patients; 30.4%), the most frequent help-
seeking causes were symptoms of anxiety (52.6%) 
and depression (52.6%). 
The total number of diagnoses per participant 
ranged from 0 to 8 (median, 2; interquartile range, 1 
to 3). The number of diagnoses was related to sex, 
with girls having more diagnoses than boys (girls: 
mean, 2.8; standard deviation, 1.7; boys: mean, 1.8, 
standard deviation, 1.3; t(123) = 3.7; p < .001). 
Eleven participants (8.8%) had no diagnoses.  
 
Prevalence of Anxiety Disorders 
Fifty-eight adolescents (46.4%; 95% confidence 
interval [CI], 37.9 to 55.1; 62.5% of all girls and 
24.5% of all boys) were diagnosed with at least one 
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anxiety disorder, with a female-to-male ratio of 3.5:1. 
The prevalences of the individual anxiety disorders 
were as follows: social anxiety, 27.2%; generalized 
anxiety, 17.6%; specific phobia, 16.8%; panic 
disorder, 9.6%; agoraphobia, 9.6%; separation 
anxiety disorder, 4.0%; and unspecified anxiety 
disorder, 1.6%. Significant associations with sex—
with more girls meeting the criteria for diagnosis—
were found for all anxiety disorders, except for 
generalized anxiety and panic disorder. The 
prevalence of anxiety disorders is presented in Table 
1. 
 
 
 
 
 
TABLE 2. Demographic and clinical presentation characteristics of anxious versus non-anxious adolescents as defined by the Schedule for 
Affective Disorders and Schizophrenia for School-Age Children 
 
Variables 
All 
Participants 
(N = 125) 
Anxious 
(n = 58) 
Non-
anxious 
(n = 67) 
t/2 (df) p value 
Demographic data      
Sex 
  Female, n (%)  72 (57.6) 
 
45 (77.6) 
 
27 (40.3) 
 
17.7 (1) 
 
<.001 
Age 
  Mean (SD) 
 
15.7 (1.5) 
 
15.8 (1.4) 
 
15.6 (1.5) 
 
0.6 (123) 
 
.521 
Ethnicity 
  Swedish, n (%)  122 (97.6) 57 (98.3) 65 (97.0) 0.2 (1) 1.000* 
Parents’ marital status 
  Divorced, n (%) 76 (60.8) 34 (58.6) 42 (62.7) 0.2 (1) .642 
Clinical presentation      
Referral source, n (%) 
  Parent 
  Primary care 
  School health services 
  Hospital departments 
  Social services 
  Other 
 
44 (35.2) 
32 (25.6) 
27 (21.6) 
6 (4.8) 
4 (3.2) 
12 (9.6) 
20 (34.5) 
19 (32.8) 
9 (15.5) 
4 (6.9) 
1 (1.7) 
5 (8.6) 
24 (35.8) 
13 (19.4) 
18 (26.9) 
2 (3.0) 
3 (4.5) 
7 (10.4) 
0.0 (1) 
2.9 (1) 
2.4 (1) 
0.8 (1) 
0.8 (1) 
0.1 (1) 
.876 
.088 
.124 
.415* 
.623* 
.729 
Referral cause, n (%) 
  ADHD symptoms 
  Depressive symptoms 
  Anxiety symptoms 
  Neurodevelopmental assessment 
  Self-harm, suicidal gestures 
  Autistic symptoms 
  Other causes 
39 (31.2) 
38 (30.4) 
23 (18.4) 
17 (13.6) 
16 (12.8) 
8 (6.4) 
20 (16.0) 
11 (19.0) 
23 (39.7) 
12 (20.7) 
10 (17.2) 
9 (15.5) 
3 (53.2) 
9 (15.5) 
28 (41.8) 
15 (22.4) 
11 (16.4) 
7 (10.4) 
7 (10.4) 
5 (7.5) 
11 (16.4) 
7.5 (1) 
4.4 (1) 
0.4 (1) 
1.2 (1) 
0.7 (1) 
0.3 (1) 
0.0 (1) 
.006 
.036 
.539 
.269 
.398 
.724* 
.891 
Prior admission to a clinic, n (%)  37 (29.6) 24 (41.4) 13 (19.4) 7.2 (1) .007 
Anxiety scores (SCAS) 
 Mean (SD) 
  Diagnostic cutoff, n (%)† 
  Screening cutoff, n (%)‡ 
 
29.8 (19.1) 
44 (35.2) 
72 (57.6) 
 
40.2 (18.3) 
35 (60.3) 
52 (86.7) 
20.2 
(14.2) 
9 (14.3) 
20 (31.7) 
 
6.7 (119) 
27.7 (1) 
42.0 (1) 
 
<.001 
<.001 
<.001 
Functional impairment/negative life events: 
Family, n (%) 
 
   
 
 
 
 
Child physical abuse§ 
Violence between parents 
  Alcohol/drug problemsa 
18 (14.4) 
16 (12.8) 
28 (22.4) 
11 (19.0) 
9 (15.5) 
16 (27.6) 
7 (10.4) 
7 (10.4) 
12 (17.9) 
1.8 (1) 
0.7 (1) 
1.7 (1) 
.176 
.398 
.196 
School, n (%) 
  Extra help/special class 
  Failed course(s) 
 
37 (29.6) 
80 (64.0) 
 
17 (29.3) 
36 (62.1) 
20 (29.9) 
44 (65.7) 
 
0.2 (1) 
1.5 (1) 
.639 
.224 
Interpersonal, n (%) 
  Bullied in school  
 
37 (29.6) 
 
22 (37.9) 
 
15 (22.4) 3.6 (1) 
 
.058 
  Difficulty making friends  28 (22.4) 21 (36.2) 7 (10.4) 11.9 (1) .001 
Somatic (pain), n (%) 71 (56.8) 46(79.3) 25 (37.3) 22.3 (1) <.001 
Sleep, n (%) 55 (44.0) 27 (46.6) 28 (41.8) 0.3 (1) .593 
No. of problems, mean (SD) b 3.0 (1.7) 3.5 (1.7) 2.5 (1.6) 3.6 (123) <.001 
ADHD, Attention-deficit/hyperactivity disorder; SCAS, Spence Children’s Anxiety Scale; SD, standard deviation 
*Fisher’s exact test, two-tailed; †Total score of 33 or more (23); ‡Total score 22 or more (23); §Participant or sibling abused by parent; 
aAny family member; b0 to 9 
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Clinical Presentation 
There were no differences between K-SADS–
defined anxious and non-anxious adolescents in 
terms of age, parents’ marital status, or ethnicity. 
However, there was a significant sex difference, with 
a higher proportion of girls found among anxious as 
compared with non-anxious adolescents (2(1) = 
17.7; p < .001). Significant differences in clinical 
presentation were found, with higher proportions of 
prior admission to the clinic (2(1) = 7.2; p = .007) 
and symptoms of depression as the referral cause 
(2(1) = 4.4; p = .036) among anxious adolescents. 
Symptoms of attention-deficit/hyperactivity 
disorder as the referral cause were more common 
among non-anxious adolescents (2(1) = 7.5; p 
= .006). Anxious adolescents rated themselves as 
having more anxiety symptoms (t(119) = 6.7; p 
< .001) and more somatic and interpersonal 
problems, with higher proportions of frequent 
symptoms of pain (2(1) = 22.3; p < 0.001) and 
difficulties making friends (2(1) = 11.9; p = .001) as 
compared with non-anxious adolescents. There were 
no significant differences with regard to referral 
source, family problems, school functioning, or sleep 
concerns. There was a tendency for a higher 
proportion of anxious than non-anxious adolescents 
to have experienced school-related bullying (2(1) = 
3.6; p = .058). Table 2 shows the demographic and 
clinical presentation characteristics of anxious and 
non-anxious adolescents. 
 
Associations between clinical presentation and anxiety 
disorders 
For each covariate, separate binary logistic regression 
analyses, which were adjusted for age and sex, were 
performed for the total sample to examine 
associations between clinical presentation and 
anxiety disorders. A referral cause of anxiety 
symptoms was not related to any anxiety disorder. 
Only 21% of K-SADS-defined anxious adolescents 
were referred for symptoms of anxiety. The category 
of “any anxiety” was associated with a referral that 
requested a neurodevelopmental assessment (odds 
ratio [OR], 4.2; 95% CI, 1.2 to 14.6; p = .023), self-
reports of frequent body ache (OR, 4.3; 95% CI, 1.7 
to 10.4; p = .001); and difficulties making new friends 
(OR, 4.5; 95% CI, 1.6 to 12.3; p = .004). Significant 
associations between generalized anxiety and clinical 
presentation were more frequently found than they 
were for the other anxiety disorders, with generalized 
anxiety being related to three variables: age (OR, 1.4; 
95% CI, 1.0 to 2.1; p = .047); referral source (i.e., 
referral from a primary care physician; OR, 3.2; 95% 
CI, 1.2 to 8.7; p = .024); and self-reports of frequent 
body ache (OR, 5.6; 95% CI, 1.4 to 23.1; p = .016). 
Panic disorder was related to a referral cause of 
depressive symptoms (OR, 4.9; 95% CI, 1.3 to 18.7; 
p = .021), as was agoraphobia (OR, 6.9; 95% CI, 1.6 
to 29.1; p = .009). Social anxiety and specific phobia 
were associated with difficulties making new friends 
(OR, 4.3; 95% CI, 1.7 to 11.1; p = .003 and OR, 3.8; 
95% CI, 1.3 to 10.7; p = .012, respectively). Analyses 
of associations between self-rated anxiety symptoms 
showed that all anxiety categories, except separation 
anxiety and unspecified anxiety disorder, were related 
to the total SCAS scores (all ORs within the 95% CI 
of 1.0 to 1.1; all p values of <.02).  
 
Patterns of Comorbidity 
Only the 58 participants who had been diagnosed 
with anxiety disorders were included in the analyses 
of comorbidity, unless otherwise specified. Three 
(5.2%) adolescents had no comorbidity (i.e., only one 
anxiety disorder).  
 
Homotypic comorbidity 
Homotypic comorbidity was found in 25 adolescents 
(43.1%; 95% CI, 31.2 to 55.9; see Table 1). 
Homotypic comorbidity without concurrent 
heterotypic comorbidity was noted in two anxiety-
disordered adolescents (3.4%). Age and sex were not 
significant predictors of total homotypic comorbidity 
among anxious adolescents, but sex was a significant 
predictor in the total sample, with more girls having 
additional anxiety disorders as compared with boys 
(OR, 7.3; 95% CI, 2.1 to 26.1; p = .002). The most 
frequent overlaps between anxiety disorders were 
social anxiety with concurrent generalized anxiety 
(20.7%) and social anxiety with concurrent specific 
phobia (20.7%). Six adolescents (10.3%) had both: 
social anxiety with concurrent generalized anxiety 
and concurrent specific phobia. In the total sample, 
the diagnoses of social anxiety, generalized anxiety, 
specific phobia, panic disorder, and separation 
anxiety disorder were significantly associated with 
the presence of additional anxiety. When analyses of 
homotypic comorbidity were limited to anxious 
adolescents, significant associations remained for the 
diagnoses of generalized anxiety, specific phobia, and 
panic disorder. Self-rated symptoms of anxiety were 
also predictive of homotypic comorbidity, which was 
congruent with associations between K-SADS–
derived anxiety disorders and homotypic 
comorbidity. In the total sample and among the 
anxiety-disordered adolescents, a total SCAS score at 
or above a diagnostic cutoff was a significant 
predictor of homotypic comorbidity, as were 
continuous measures of total anxiety symptoms and 
disorder-specific symptoms. Among referral causes, 
the only significant predictor of homotypic 
comorbidity was found in the total sample with the 
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referral cause of autistic symptoms (OR, 9.6; 95% CI, 
1.1 to 80.6; p = .037). Adjusted ORs for the 
association between anxiety disorders, self-rated 
anxiety symptoms, and homotypic comorbidity are 
presented separately for the total and anxious 
samples in Table 3.  
 
 
 
 
TABLE 3. Adjusted odds ratios with 95% confidence intervals for the association between anxiety disorders, anxiety symptoms, and homotypic 
comorbidity 
 
 Homotypic Comorbidity 
 
Covariates* Total Sample (N = 125) Anxious Sample (n = 58) 
 OR 95% CI p value OR 95% CI p value 
Anxiety disorders       
Social anxiety 11.560 3.832–34.872 <.001 2.949 0.909–9.573 .072 
Generalized anxiety 23.812 6.429–88.187 <.001 7.226 1.857–28.122 .004 
Specific phobia 18.060 5.492–59.392 <.001 6.148 1.813–20.848 .004 
Panic disorder 105.275 9.313–1189.995 <.001 38.185 3.437–
424.235 
.003 
Agoraphobia +∞† – – +∞† – – 
Separation anxiety disorder 13.503 1.337–136.390 .027 6.476 0.611–68.663 .121 
Unspecified anxiety disorder –∞† – – –∞† – – 
Anxiety symptoms (Spence Children’s 
Anxiety Scale, self-report)  
      
Diagnostic cutoff‡ 11.420 3.336–39.094 <.001 5.664 1.498–21.414 .011 
Screening cutoffa 6.706 1.402–32.075 .017 0.666 0.085–5.188 .698 
Total scoreb 1.073 1.037–1.112 <.001 1.061 1.017–1.106 .006 
Social anxietyb 1.327 1.146–1.537 <.001 1.229 1.032–1.463 .021 
Generalized anxiety disorderb 1.328  1.144–1.542 <.001 1.212 1.024–1.435 .025 
Physical injury fears (specific phobia) b 1.187 1.004–1.404 .044 1.134 0.933–1.379 .206 
Panic/agoraphobiab 1.254 1.123–1.401 <.001 1.173 1.042–1.321 .009 
Separation anxietyb 1.338 1.139–1.572 <.001 1.277 1.056–1.543 .011 
CI, Confidence interval; OR, odds ratio. 
*Each multivariate model included a single covariate adjusted for age and sex. 
+∞†Diagnosis was only present without homotypic comorbidity; –∞†Diagnosis was only present without homotypic comorbidity; ‡Total score of 33 
or more (23); aTotal score of 22 or more (23); bContinuous scores. 
 
 
 
 
Heterotypic comorbidity 
Categories of K-SADS–derived heterotypic 
comorbid diagnoses are presented as supplementary 
material (see Table S1). Heterotypic comorbidity was 
found in 53 anxiety-disordered adolescents (91.4%; 
95% CI, 81.4 to 96.3). Heterotypic comorbidity 
without concurrent homotypic comorbidity was 
found in 30 adolescents (51.7%). Logistic regression 
analyses showed that no specific anxiety disorder was 
significantly associated with increased odds of overall 
heterotypic comorbidity. In separate multivariate 
models, adjusted for age and sex, single anxiety 
disorders were used as independent variables, in 
logistic regression analyses of associations between 
the four most frequent heterotypic categories and 
individual anxiety disorders. Significant relationships 
between three heterotypic categories and four 
anxiety disorders were observed: trauma disorders 
and panic disorder (OR, 8.6; 95% CI, 1.6 to 46.1; p 
= .012); trauma disorders and social anxiety (OR, 0.1; 
95% CI, 0.1 to 0.6; p  = .011); depressive disorders 
and generalized anxiety (OR, 4.1; 95% CI, 1.2 to 13.9; 
p  = .024); and conduct disorders and agoraphobia 
(OR, 5.7; 95% CI, 1.1 to 29.9; p = .040). Overall, 
significantly higher rates of trauma-related disorders 
were observed among adolescents with anxiety than 
in those without (15.5% vs. 4.5%; p = .037). There 
were no other significant differences in heterotypic 
comorbid categories between anxious and non-
anxious adolescents. Heterotypic comorbidity in the 
total sample and separately for anxious and non-
anxious adolescents is presented in Table 1. 
 
Discussion 
This study examined the characteristics of seven 
anxiety disorders in a sample of 125 adolescents who 
were consecutively referred to psychiatric outpatient 
clinics for multiple causes. At least one anxiety 
disorder was found in 46.4% of adolescents, with 
girls diagnosed more than three times more often 
than boys. The most frequent anxiety disorder was 
social anxiety (27.2%), whereas the least frequent 
were separation anxiety (4.0%) and unspecified 
anxiety disorder (1.6%). Conspicuous differences in 
clinical presentation between anxious and non-
anxious adolescents were higher levels of self-rated 
anxiety symptoms, higher proportions of prior 
admission, and more frequent reporting of 
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depression as the referral cause. As compared with 
psychiatrically referred adolescents without anxiety, 
anxious adolescents reported more symptoms of 
pain and difficulties making friends. Nearly all 
adolescents who were diagnosed with anxiety 
disorders had concurrent disorders, with heterotypic 
comorbidity being twice as common as homotypic 
comorbidity.  
To the best of our knowledge, there are no 
comparable reports involving the use of a diagnostic 
interview to investigate the specific characteristics of 
multiple anxiety disorders among adolescents with 
multiple referral causes in a non-specialized 
psychiatric setting. Previous studies of youths 
referred specifically for anxiety treatment have found 
differences in clinical characteristics between 
children and adolescents with regard to prevalence 
rates, especially for separation anxiety disorder 
(which is uncommon among adolescents) and 
symptom severity (which has been found to be 
significantly higher among adolescents) (27, 28). 
Thus, relating the findings of the current study to 
three previously reported studies of prevalence in 
non-specialized psychiatry is curtailed, because the 
other studies all included either combined samples of 
children and adolescents or only younger children 
(12-14). With this limitation in mind, the prevalence 
of any anxiety disorder observed in this study is more 
akin to the estimates of 57.7% reported by 
Hammerness and colleagues in the United States (13) 
and 32.7% reported by Hansen and colleagues in 
Norway (14) rather than to the rate of 5.7% reported 
by Esbjørn and colleagues in Denmark (12). This 
must be viewed in relation to the methodological 
similarities and differences of these studies. 
Similarities included the setting and the inclusion of 
participants irrespective of referral cause. 
Dissimilarities in the current study as compared with 
previous studies were as follows: 1) a higher 
proportion of girls; 2) the age range (i.e., only 
adolescents); and 3) the categories and number of 
studied anxiety disorders. The low-prevalence 
Danish study differs from both the current study, 
North American and Norwegian studies in the same 
way: it used ICD-10 criteria, as well as 
unstandardized diagnostic assessments. However, 
not even the 95% CI (37.9 to 55.1%) surrounding the 
observed prevalence of any anxiety in the current 
study included the reported estimates from the 
United States and Norway, although the same K-
SADS diagnostic interview was used. It is worth 
noting that the described between-study differences 
listed previously are analogous to some of the 
findings reported by Baxter and colleagues in their 
meta-analysis of sources of anxiety prevalence 
variability in community studies (18). Specifically, 
Baxter and colleagues found that sex explained 25% 
of the variance and that there was no effect of the 
diagnostic instrument after the number of disorders 
was considered. This observation suggests that 
anxiety prevalence variability in community and 
clinical studies may be influenced by the same 
moderators, although further research is needed to 
understand their specific impact on child and 
adolescent psychiatry. 
As can be expected in a general psychiatric sample 
that includes patients with multiple referral causes, 
total comorbidity among anxiety-disordered 
adolescents was very high, with only 5% being 
diagnosed with one single anxiety disorder and no 
other concurrent disorders. Overall homotypic 
comorbidity was in line with the findings reported by 
Hammerness and colleagues in the United States 
(13), with most anxiety disorders associated with 
additional diagnoses of anxiety. Although 
comorbidity estimates reported by Esbjørn and 
colleagues in Denmark (12) and by Hansen and 
colleagues in Norway (14) were markedly lower as 
compared with the findings of the current study, 
observations of heterotypic comorbidity as the more 
prevalent type were similar. Moreover, the 
percentage point (pp) differences between homotypic 
and heterotypic comorbidity in those studies (40 pp 
and 46 pp) were similar to the difference observed in 
the current study (48 pp), which implies that this 
comorbidity pattern is a clinical characteristic that 
can be expected among anxious youths in non-
anxiety–specialized psychiatric settings. The more 
frequently observed heterotypic comorbidity could 
also be a possible explanation for the low anxiety 
prevalence estimates observed in patient registers in 
Denmark and Norway and in the current study 
clinics before data collection, if in fact the heterotypic 
comorbidity was the primary cause for the seeking of 
help and diagnostic procedures inadequately assessed 
the presence of concurrent disorders.  
As has been seen in other studies, self-ratings of 
family, interpersonal, school, sleep, and somatic 
functioning among anxious adolescents revealed 
problems in all areas. Few significant differences in 
domain function were found between anxious and 
non-anxious adolescents, but the frequency and co-
occurrence of the inquired problems with anxiety still 
warrant noting. However, although a high 
proportion of anxious adolescents rated themselves 
as having functional impairment or difficulties in 
multiple areas, the impairment of these adolescents 
cannot be attributed to anxiety specifically because 
the intake questionnaire was designed to measure 
overall functioning, regardless of presenting 
symptoms. Nonetheless, the clinical correlates of 
anxiety disorders observed in this study have been 
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associated with more chronicity and negative 
outcomes, and they call attention to the necessity of 
comprehensive assessment and proficient treatment 
planning to fully attend to the complexity of 
symptoms in this patient group (5, 29-33). 
Finally, in line with the findings of the Norwegian 
study (14), we determined that a referral cause of 
anxiety was an inadequate method for identifying 
adolescents with anxiety, because it yielded a 
sensitivity of only 21 %. 
 
Strengths 
There are several indicators of the validity and 
generalizability of the current investigation. First, 
participants were consecutively included irrespective 
of referral cause or presenting symptoms. Second, 
the diagnostic assessments were based on a 
standardized interview, thereby increasing both 
diagnostic precision and detection. Third, data 
collection was conducted in a non-anxiety–
specialized setting and is thus likely to be 
generalizable to standard clinical care settings. 
Fourth, the proportion of girls observed in the 
current sample (58%) was similar to the proportion 
observed in referrals to the clinics during the 6-
month period that followed the end of the study 
(63%). 
 
Limitations 
Several limitations of the current study should be 
acknowledged. Only 13 boys met the diagnostic 
criteria for an anxiety disorder, thus precluding 
analyses of sex differences beyond the prevalence of 
any anxiety disorder. A majority of parents did not 
report their educational level or socioeconomic 
status, which precluded the analysis of these 
demographics in relation to anxiety. Whereas the 
administration of the K-SADS typically involves 
separate interviews, adolescents and parents were 
interviewed together in the current study, which may 
have had an effect on the inclination of both 
informants to describe psychiatric symptoms. 
Moreover, diagnoses were based only on information 
collected during the K-SADS interview; interviewers 
were unaware of the results of questionnaires 
completed at intake or other additional information 
sources. This diagnostic procedure requires patients 
to be able to adequately recognize and verbalize their 
feelings and behaviors, but these skills can be 
impaired in psychiatrically referred youths for various 
reasons. 
 
Clinical Significance 
For the detection of anxiety disorders among 
adolescents referred to non–anxiety-specialized child 
and adolescent psychiatry, the findings of this study 
provide further evidence for the referral cause of 
anxiety being an inadequate method, with detection 
rates ranging from only 21% for any anxiety to 50% 
for the diagnosis of unspecified anxiety. Thus, this 
study provides further support for the routine use of 
standardized and structured instruments to improve 
both the precision and detection rates of anxiety in 
this setting. This study also adds important 
information about clinical presentation and 
comorbidity patterns, and it underscores the 
importance of comprehensive assessment to fully 
address the complexity of the symptoms in this 
patient group. 
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